Bicycle Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	261	418	934	694	822	1,574
Market Cap Growth	-57.49%	-55.20%	34.56%	-15.62%	-47.74%	403.33%
Enterprise Value	-270	-129	84	218	525	1,374
Last Close Price	3.62	5.50	13.30	16.20	26.60	49.60
PS Ratio	4.22	6.77	27.40	28.43	60.76	152.99
PB Ratio	0.50	0.81	1.22	2.07	3.25	5.17
P/TBV Ratio	0.50	0.81	1.22	2.07	3.25	5.17
EV/Sales Ratio	-	-	2.46	8.92	38.82	133.63
Debt / Equity Ratio	0.03	0.03	0.01	0.12	0.16	0.13
Net Debt / Equity Ratio	-1.00	-1.00	-1.10	-1.30	-1.09	-1.14
Net Debt / EBITDA Ratio	2.59	2.59	4.32	2.63	2.61	6.14
Net Debt / FCF Ratio	2.42	2.42	5.24	7.58	2.81	23.44
Asset Turnover	0.09	0.09	0.05	0.05	0.03	0.04
Quick Ratio	11.65	11.65	13.61	7.92	6.76	12.43
Current Ratio	11.98	11.98	13.81	8.08	6.93	12.65
Return on Equity (ROE)	-31.21%	-31.21%	-29.04%	-56.31%	-36.54%	-30.25%
Return on Assets (ROA)	-18.13%	-18.13%	-16.81%	-23.60%	-16.38%	-12.80%
Return on Capital Employed (ROCE)	-36.80%	-36.80%	-23.50%	-36.10%	-32.70%	-14.80%
Earnings Yield	-71.51%	-44.58%	-17.49%	-23.55%	-12.83%	-3.73%
FCF Yield	-82.31%	-51.32%	-17.17%	-8.29%	-11.96%	-0.94%
Buyback Yield / Dilution	-19.02%	-19.02%	-63.54%	-20.00%	-18.35%	-30.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.